0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Parenteral PrEP Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-30J18115
Home | Market Reports | Health| Pharmacy
Global Parenteral PrEP Market Research Report 2024
BUY CHAPTERS

Global Parenteral PrEP Market Research Report 2024

Code: QYRE-Auto-30J18115
Report
October 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Parenteral PrEP Market

Parenteral PrEP refers to a form of Pre-Exposure Prophylaxis (PrEP) for HIV prevention that is administered via injection, rather than orally. It involves the use of long-acting injectable antiretroviral drugs, such as cabotegravir, which are delivered intramuscularly at regular intervals, typically every 1 to 2 months. Parenteral PrEP offers an alternative for individuals who may have difficulty adhering to daily oral PrEP regimens, providing prolonged protection against HIV.
The global Parenteral PrEP market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Parenteral PrEP is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Parenteral PrEP is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Parenteral PrEP include Gilead Sciences, ViiV Healthcare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Parenteral PrEP, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral PrEP.
The Parenteral PrEP market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Parenteral PrEP market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parenteral PrEP manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Parenteral PrEP Market Report

Report Metric Details
Report Name Parenteral PrEP Market
Segment by Type
  • Cabotegravir
  • Lenacapavir
  • Other
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gilead Sciences, ViiV Healthcare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Parenteral PrEP manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Parenteral PrEP in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Parenteral PrEP Market report?

Ans: The main players in the Parenteral PrEP Market are Gilead Sciences, ViiV Healthcare

What are the Application segmentation covered in the Parenteral PrEP Market report?

Ans: The Applications covered in the Parenteral PrEP Market report are Subcutaneous Use, Intramuscular Use

What are the Type segmentation covered in the Parenteral PrEP Market report?

Ans: The Types covered in the Parenteral PrEP Market report are Cabotegravir, Lenacapavir, Other

Recommended Reports

HIV Prevention & Therapy

Sample & Media Preparation

Parenteral & Drug Delivery

1 Parenteral PrEP Market Overview
1.1 Product Definition
1.2 Parenteral PrEP by Type
1.2.1 Global Parenteral PrEP Market Value Comparison by Type (2024-2030)
1.2.2 Cabotegravir
1.2.3 Lenacapavir
1.2.4 Other
1.3 Parenteral PrEP by Application
1.3.1 Global Parenteral PrEP Market Value by Application (2024-2030)
1.3.2 Subcutaneous Use
1.3.3 Intramuscular Use
1.4 Global Parenteral PrEP Market Size Estimates and Forecasts
1.4.1 Global Parenteral PrEP Revenue 2019-2030
1.4.2 Global Parenteral PrEP Sales 2019-2030
1.4.3 Global Parenteral PrEP Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Parenteral PrEP Market Competition by Manufacturers
2.1 Global Parenteral PrEP Sales Market Share by Manufacturers (2019-2024)
2.2 Global Parenteral PrEP Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Parenteral PrEP Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Parenteral PrEP, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Parenteral PrEP, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Parenteral PrEP, Product Type & Application
2.7 Global Key Manufacturers of Parenteral PrEP, Date of Enter into This Industry
2.8 Global Parenteral PrEP Market Competitive Situation and Trends
2.8.1 Global Parenteral PrEP Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Parenteral PrEP Players Market Share by Revenue
2.8.3 Global Parenteral PrEP Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Parenteral PrEP Market Scenario by Region
3.1 Global Parenteral PrEP Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Parenteral PrEP Sales by Region: 2019-2030
3.2.1 Global Parenteral PrEP Sales by Region: 2019-2024
3.2.2 Global Parenteral PrEP Sales by Region: 2025-2030
3.3 Global Parenteral PrEP Revenue by Region: 2019-2030
3.3.1 Global Parenteral PrEP Revenue by Region: 2019-2024
3.3.2 Global Parenteral PrEP Revenue by Region: 2025-2030
3.4 North America Parenteral PrEP Market Facts & Figures by Country
3.4.1 North America Parenteral PrEP Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Parenteral PrEP Sales by Country (2019-2030)
3.4.3 North America Parenteral PrEP Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Parenteral PrEP Market Facts & Figures by Country
3.5.1 Europe Parenteral PrEP Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Parenteral PrEP Sales by Country (2019-2030)
3.5.3 Europe Parenteral PrEP Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Parenteral PrEP Market Facts & Figures by Region
3.6.1 Asia Pacific Parenteral PrEP Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Parenteral PrEP Sales by Region (2019-2030)
3.6.3 Asia Pacific Parenteral PrEP Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Parenteral PrEP Market Facts & Figures by Country
3.7.1 Latin America Parenteral PrEP Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Parenteral PrEP Sales by Country (2019-2030)
3.7.3 Latin America Parenteral PrEP Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Parenteral PrEP Market Facts & Figures by Country
3.8.1 Middle East and Africa Parenteral PrEP Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Parenteral PrEP Sales by Country (2019-2030)
3.8.3 Middle East and Africa Parenteral PrEP Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Parenteral PrEP Sales by Type (2019-2030)
4.1.1 Global Parenteral PrEP Sales by Type (2019-2024)
4.1.2 Global Parenteral PrEP Sales by Type (2025-2030)
4.1.3 Global Parenteral PrEP Sales Market Share by Type (2019-2030)
4.2 Global Parenteral PrEP Revenue by Type (2019-2030)
4.2.1 Global Parenteral PrEP Revenue by Type (2019-2024)
4.2.2 Global Parenteral PrEP Revenue by Type (2025-2030)
4.2.3 Global Parenteral PrEP Revenue Market Share by Type (2019-2030)
4.3 Global Parenteral PrEP Price by Type (2019-2030)
5 Segment by Application
5.1 Global Parenteral PrEP Sales by Application (2019-2030)
5.1.1 Global Parenteral PrEP Sales by Application (2019-2024)
5.1.2 Global Parenteral PrEP Sales by Application (2025-2030)
5.1.3 Global Parenteral PrEP Sales Market Share by Application (2019-2030)
5.2 Global Parenteral PrEP Revenue by Application (2019-2030)
5.2.1 Global Parenteral PrEP Revenue by Application (2019-2024)
5.2.2 Global Parenteral PrEP Revenue by Application (2025-2030)
5.2.3 Global Parenteral PrEP Revenue Market Share by Application (2019-2030)
5.3 Global Parenteral PrEP Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Company Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Parenteral PrEP Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Gilead Sciences Parenteral PrEP Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 ViiV Healthcare
6.2.1 ViiV Healthcare Company Information
6.2.2 ViiV Healthcare Description and Business Overview
6.2.3 ViiV Healthcare Parenteral PrEP Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ViiV Healthcare Parenteral PrEP Product Portfolio
6.2.5 ViiV Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Parenteral PrEP Industry Chain Analysis
7.2 Parenteral PrEP Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Parenteral PrEP Production Mode & Process
7.4 Parenteral PrEP Sales and Marketing
7.4.1 Parenteral PrEP Sales Channels
7.4.2 Parenteral PrEP Distributors
7.5 Parenteral PrEP Customers
8 Parenteral PrEP Market Dynamics
8.1 Parenteral PrEP Industry Trends
8.2 Parenteral PrEP Market Drivers
8.3 Parenteral PrEP Market Challenges
8.4 Parenteral PrEP Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Parenteral PrEP Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Parenteral PrEP Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Parenteral PrEP Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Parenteral PrEP Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Parenteral PrEP Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Parenteral PrEP Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Parenteral PrEP Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Parenteral PrEP Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Parenteral PrEP, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Parenteral PrEP, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Parenteral PrEP, Product Type & Application
 Table 12. Global Key Manufacturers of Parenteral PrEP, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Parenteral PrEP by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral PrEP as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Parenteral PrEP Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Parenteral PrEP Sales by Region (2019-2024) & (K Units)
 Table 18. Global Parenteral PrEP Sales Market Share by Region (2019-2024)
 Table 19. Global Parenteral PrEP Sales by Region (2025-2030) & (K Units)
 Table 20. Global Parenteral PrEP Sales Market Share by Region (2025-2030)
 Table 21. Global Parenteral PrEP Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Parenteral PrEP Revenue Market Share by Region (2019-2024)
 Table 23. Global Parenteral PrEP Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Parenteral PrEP Revenue Market Share by Region (2025-2030)
 Table 25. North America Parenteral PrEP Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Parenteral PrEP Sales by Country (2019-2024) & (K Units)
 Table 27. North America Parenteral PrEP Sales by Country (2025-2030) & (K Units)
 Table 28. North America Parenteral PrEP Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Parenteral PrEP Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Parenteral PrEP Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Parenteral PrEP Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Parenteral PrEP Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Parenteral PrEP Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Parenteral PrEP Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Parenteral PrEP Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Parenteral PrEP Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Parenteral PrEP Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Parenteral PrEP Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Parenteral PrEP Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Parenteral PrEP Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Parenteral PrEP Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Parenteral PrEP Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Parenteral PrEP Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Parenteral PrEP Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Parenteral PrEP Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Parenteral PrEP Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Parenteral PrEP Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Parenteral PrEP Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Parenteral PrEP Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Parenteral PrEP Sales (K Units) by Type (2019-2024)
 Table 51. Global Parenteral PrEP Sales (K Units) by Type (2025-2030)
 Table 52. Global Parenteral PrEP Sales Market Share by Type (2019-2024)
 Table 53. Global Parenteral PrEP Sales Market Share by Type (2025-2030)
 Table 54. Global Parenteral PrEP Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Parenteral PrEP Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Parenteral PrEP Revenue Market Share by Type (2019-2024)
 Table 57. Global Parenteral PrEP Revenue Market Share by Type (2025-2030)
 Table 58. Global Parenteral PrEP Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Parenteral PrEP Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Parenteral PrEP Sales (K Units) by Application (2019-2024)
 Table 61. Global Parenteral PrEP Sales (K Units) by Application (2025-2030)
 Table 62. Global Parenteral PrEP Sales Market Share by Application (2019-2024)
 Table 63. Global Parenteral PrEP Sales Market Share by Application (2025-2030)
 Table 64. Global Parenteral PrEP Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Parenteral PrEP Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Parenteral PrEP Revenue Market Share by Application (2019-2024)
 Table 67. Global Parenteral PrEP Revenue Market Share by Application (2025-2030)
 Table 68. Global Parenteral PrEP Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Parenteral PrEP Price (US$/Unit) by Application (2025-2030)
 Table 70. Gilead Sciences Company Information
 Table 71. Gilead Sciences Description and Business Overview
 Table 72. Gilead Sciences Parenteral PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Gilead Sciences Parenteral PrEP Product
 Table 74. Gilead Sciences Recent Developments/Updates
 Table 75. ViiV Healthcare Company Information
 Table 76. ViiV Healthcare Description and Business Overview
 Table 77. ViiV Healthcare Parenteral PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. ViiV Healthcare Parenteral PrEP Product
 Table 79. ViiV Healthcare Recent Developments/Updates
 Table 80. Key Raw Materials Lists
 Table 81. Raw Materials Key Suppliers Lists
 Table 82. Parenteral PrEP Distributors List
 Table 83. Parenteral PrEP Customers List
 Table 84. Parenteral PrEP Market Trends
 Table 85. Parenteral PrEP Market Drivers
 Table 86. Parenteral PrEP Market Challenges
 Table 87. Parenteral PrEP Market Restraints
 Table 88. Research Programs/Design for This Report
 Table 89. Key Data Information from Secondary Sources
 Table 90. Key Data Information from Primary Sources
 Table 91. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Parenteral PrEP
 Figure 2. Global Parenteral PrEP Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Parenteral PrEP Market Share by Type: 2023 & 2030
 Figure 4. Cabotegravir Product Picture
 Figure 5. Lenacapavir Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Parenteral PrEP Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Parenteral PrEP Market Share by Application: 2023 & 2030
 Figure 9. Subcutaneous Use
 Figure 10. Intramuscular Use
 Figure 11. Global Parenteral PrEP Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Parenteral PrEP Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Parenteral PrEP Sales (2019-2030) & (K Units)
 Figure 14. Global Parenteral PrEP Average Price (US$/Unit) & (2019-2030)
 Figure 15. Parenteral PrEP Report Years Considered
 Figure 16. Parenteral PrEP Sales Share by Manufacturers in 2023
 Figure 17. Global Parenteral PrEP Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Parenteral PrEP Players: Market Share by Revenue in Parenteral PrEP in 2023
 Figure 19. Parenteral PrEP Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Parenteral PrEP Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Parenteral PrEP Sales Market Share by Country (2019-2030)
 Figure 22. North America Parenteral PrEP Revenue Market Share by Country (2019-2030)
 Figure 23. United States Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Parenteral PrEP Sales Market Share by Country (2019-2030)
 Figure 26. Europe Parenteral PrEP Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Parenteral PrEP Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Parenteral PrEP Revenue Market Share by Region (2019-2030)
 Figure 34. China Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Parenteral PrEP Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Parenteral PrEP Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Parenteral PrEP Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Parenteral PrEP Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Parenteral PrEP by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Parenteral PrEP by Type (2019-2030)
 Figure 53. Global Parenteral PrEP Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Parenteral PrEP by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Parenteral PrEP by Application (2019-2030)
 Figure 56. Global Parenteral PrEP Price (US$/Unit) by Application (2019-2030)
 Figure 57. Parenteral PrEP Value Chain
 Figure 58. Parenteral PrEP Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart